OBJECTIVES The aim of this study was to describe the role of contrast-enhanced cardiac magnetic resonance (CMR) in the workup of patients with aborted sudden cardiac arrest (SCA) and in the prediction of long-term outcomes.
are the 2 most common arrhythmias detected among survivors of SCA (5) (6) (7) . Myocardial scar is a key substrate for the generation and maintenance of malignant ventricular arrhythmias (8) (9) (10) . Tissue characterization and the identification of myocardial scar using late gadolinium enhancement (LGE) are key strengths of cardiac magnetic resonance (CMR) (11, 12) . There are limited data testing the role of CMR in the workup of survivors of SCA (4) . Therefore, our first goal was to add to this limited data set and test the role of the unique tissue characterization provided by CMR in the workup of survivors of SCA.
Furthermore, myocardial scar by LGE has been shown to identify the origin of ventricular arrhythmias (10, 13) , and LGE has been shown to be a key predictor of subsequent adverse events in patients with implantable cardioverter-defibrillators (ICDs) placed for primary prevention of sudden cardiac death (14) (15) (16) . Survivors of SCA are at significantly increased risk of subsequent adverse cardiac events, with a mortality rate approaching 10% per year despite ICD insertion (5, 6, 17) . However, there are no data testing the role of the presence and extent of LGE for prediction of subsequent adverse events among survivors of SCA. Therefore, in a second aim, we wanted to test the role of the presence and extent of LGE for the prediction of subsequent adverse events among survivors of SCA. Our hypothesis was that a CMR study through detection of LGE would identify a potential arrhythmic substrate among survivors of SCA and that the presence and extent of LGE would be a discriminator of subsequent adverse events after ICD insertion.
METHODS STUDY POPULATION.
We conducted a combination prospective and retrospective study.
We prospectively collected data on consecutive patients resuscitated from SCA who underwent a CMR study and performed a retrospective follow-up for adverse events.
SCA was defined as the sudden cessation of effective cardiac mechanical activity, resulting in unresponsiveness without normal breathing or signs of circulation (18) LGE and Sudden Cardiac Arrest assessment, ECG, echocardiogram, and coronary angiogram that did not reveal a clear etiology for the SCA. We excluded patients diagnosed with acute myocardial infarction (MI) or who underwent revascularization at the time of admission. A prior MI was defined as either clinical evidence of an MI per electronic medical records or ECG evidence defined by Minnesota codes 1.1.1 to 1.2.8 (19) . Medications were recorded at the time of discharge from the hospital.
The protocol was approved by the Human Subjects Review Committee of both hospitals.
CMR PROTOCOL. All images were acquired with ECG gating, breath-holding, and the patient in a supine position, as previously described (16) . Subjects were imaged on either a 1.5-T or 3.0-T CMR system (Signa CV/I HDXt platform, General Electric Healthcare, Waukesha, Wisconsin, or Tim Trio, Siemens, Erlangen, Germany, respectively). Both CMR protocols consisted of cine steady-state free precession imaging for cardiac function and LGE imaging for myocardial fibrosis (16, (20) (21) (22) . All images were analyzed with specialized software (Mass Research, University Medical Centre, Leiden, the Netherlands) by researchers blinded to clinical outcomes (16) .
LATE GADOLINIUM ENHANCEMENT.
LGE was considered present only if confirmed on both short-axis and matching long-axis myocardial locations. The presence and pattern of LGE was confirmed by 2 level 3 CMR experts blinded to all other clinical data. LGE was quantified by using regions defined as more than 50% of maximal signal intensity of the enhanced area (full width at half maximum [FWHM] ) (16) In the first model, we included the presence of LGE; in the second, we included the extent of LGE. To find the best overall multivariable model for the composite endpoint, we used a stepwise-backward selection with a probability to remove the effect from the regression at p > 0.05. The proportional-hazards assumption was met in all models, and all models fit the data well. Event curves were determined according to the Kaplan-Meier method, and comparisons of cumulative event rates were performed by the log-rank test. A receiver-operating characteristic (ROC) curve was constructed to determine the optimal value with the maximum sensitivity and specificity of LGE extent to predict adverse cardio- 
RESULTS
The number of patients referred for a CMR study for workup of SCA was 147 (Figure 1) . From these 147 patients, there were 137 with a diagnosis that was not clear before the CMR study ( Table 1) . The presenting arrhythmias were VF (n ¼ 105 [77%]) and VT (n ¼ 32
[23%]). The average LVEF was 43 AE 12% and RVEF was 45 AE 12% ( Table 2) . Of the entire cohort, 96 patients (70%) had an LVEF of <50% at the time of CMR.
LATE GADOLINIUM ENHANCEMENT.
LGE was present in 98 patients (71%) ( Table 2 ). The LGE pattern was subendocardial in 46 (47%), transmural in 20 (21%), mid-myocardial in 23 (23%), epicardial in 8 (8%), and at the insertion point of the RV in 1 of the patients (1%). The average extent of LGE was 9.9 AE 5% of the LV myocardium. Patients were grouped according to the presence or absence of LGE (Tables 1   and 2 ). VT was more commonly the presenting arrhythmia in patients with LGE, and VF was more common in those without LGE. There was a higher percentage of men in the LGE-negative group; otherwise, there were no significant differences between patients with and without LGE.
IDENTIFICATION OF AN ARRHYTHMIC SUBSTRATE.
Among the 137 patients who were referred for a contrast CMR study for workup of SCA, a diagnosis or LGE FWHM (% of LV mass) 9.9 AE 5.0
LGE location 
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LGE and Sudden Cardiac Arrest Values are mean AE SD or n (%).
Abbreviations as in Tables 1 and 2 . Values are mean AE SD or n (%).
MACE ¼ major adverse cardiac events; other abbreviations as in Table 1 .
LGE provided strong and independent prognostic information among this high-risk cohort. VT. In that study, the mean LVEF was 60%, onethird underwent ICD insertion, and one-third had
LGE. The pattern of LGE was nonischemic in twothird and ischemic in one-third. They found that the presence of LGE provided stronger prognostic information than LVEF. Among patients with resuscitated SCA, we found that both the presence and the extent of LGE were associated with a markedly increased rate of subsequent adverse events. There Tables 1, 3 , and 5. Abbreviations as in Tables 1, 2 , 3, 5 and 6. Tables 1 and 2 . therapy. In the AVID study, the mean LVEF was 32% (7), whereas, in the CIDS (Canadian Implantable Defibrillator Study) trial, which enrolled a similar study cohort, the mean LVEF was 34% (5). In the CASH (Cardiac Arrest Study Hamburg) study, the mean LVEF was 45% (6), similar to that reported in an observational population study of survivors of SCA (33) . Our study cohort consisted of patients who were broadly similar. We found a mean LVEF of 41%
and a similar presenting arrhythmia. This study does not provide mechanistic insight into the cause of the ischemic pattern of LGE, but possibilities include vasospasm, embolism, myocarditis, and occult plaque rupture (34) . We also recorded the medical therapy at the time of discharge; therefore, how therapy was modified over time was not captured and how the presence of LGE influenced therapy is unknown.
CONCLUSIONS
Among patients resuscitated from SCA who were referred for CMR study, we found that a contrast CMR study provided added value, especially among patients in whom the diagnosis was unclear after an initial standard workup. Neilan et al.
